Robert Gunning

Comptroller/Controller/Auditor bij FRAZIER LIFESCIENCES ACQUISITION CORPORATION

55 jaar

Health Technology

Consumer Services

Profiel

Robert W.
Gunning is currently Principal Accounting Officer, VP & Controller at NewAmsterdam Pharma Co. NV since 2026.
Formerly, Mr. Gunning was Controller at Altimmune, Inc. in 2026 and Vice President-Finance & Controller at Y-mAbs Therapeutics, Inc. from 2022 to 2026.
Mr. Gunning completed undergraduate education at Pace University.

Actieve functies van Robert Gunning

Bedrijven	Functie	Begin
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Comptroller/Controller/Auditor	10-08-2026

Alle actieve functies van Robert Gunning

Eerdere bekende functies van Robert Gunning

Bedrijven	Functie	Einde
ALTIMMUNE, INC.	Comptroller/Controller/Auditor	01-07-2026
YMAS THER	Comptroller/Controller/Auditor	01-04-2026

Ervaring van Robert Gunning in detail bekijken

Opleiding van Robert Gunning

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Robert Gunning in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	4
Pace University Pace University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Y-mAbs Therapeutics, Inc. Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer	Health Technology
Altimmune, Inc. Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals	Health Technology
NewAmsterdam Pharma Co. NV NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases	Health Technology